Atara Biotherapeutics, Inc

ATRANASDAQUSD
10.51 USD
0.29 (2.84%)AT CLOSE (11:59 AM EDT)
10.48
0.04 (0.33%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
10.48
0.04 (0.33%)
🔴Market: CLOSED

Atara Biotherapeutics, Inc (ATRA) trades at $10.51 per share. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, exceptional Return on Equity (25.4%) and a bearish Death Cross on the long-term moving averages. Valuation metrics place ATRA at a fair price relative to peers.

Technical & fundamental data as of Jun 26, 2026.

Open?$10.20
High?$10.71
Low?$10.15
Prev. Close?$10.22
Volume?45.3K
Avg. Volume?122.8K
VWAP?$10.33
Rel. Volume?0.37x
Bid / Ask
Bid?$9.90 × 2.0K
Ask?$10.79 × 100
Spread?$0.89
Midpoint?$10.34
Valuation & Ratios
Market Cap?94.7M
Shares Out?9.0M
Float?2.6M
Float %?36.0%
P/E Ratio?N/A
P/B Ratio?-2.54
EPS?-$1.05
Dividend?0.00%
Ex-Dividend?N/A
RelatedORIC
News
Profile
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.
Employees
13
Market Cap
92.1M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2014-10-16
Address
1280 RANCHO CONEJO BLVD
THOUSAND OAKS, CA 91320
Phone: 805-623-4211
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+1/3)
Medium-Term (Wave)? Bullish(+1/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
2
Short Sent.?
45
Piotroski F-Score?1/9Weak
Altman Z-Score?-140.34Distress
Confidence?59%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?19.00%High
Short Interest?492.4K
Days to Cover?6.3
Free Float2.6M
Avg Daily Volume78.6K
Settlement Date2026-06-15
Financial Health
Current Ratio?2.16Strong
Quick Ratio?2.16Strong
Cash Ratio?1.48Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A
P/B?
Peers
100
S&P
97
-2.54CHEAP
P/S?
S&P
37
4.09FAIR
P/FCF?
N/A
EV/EBITDA?
S&P
97
-14.5CHEAP
EV/Sales?
S&P
50
3.73FAIR
Returns & Efficiency
ROE?
S&P
74
25.4%STRONG
ROA?
S&P
3
-47.3%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$86.3M
Fundamentals ratios updated end of day